Healthcare | August 03, 2021
Nureca Ltd PAT at Rs 36.19 crore in Q1FY22
Nureca Ltd has reported financial results for the period ended June 30, 2021.
Nureca Ltd has reported financial results for the period ended June 30, 2021.
Drug formulations and biologics make impressive gains
India business is growing as per projections; whereas US business will bounce back soon.
Takeda Will Focus its Efforts on Dengue, Zika and Pandemic vaccines
Price band in the range of Rs 933 to Rs 954
The company posted net profit of Rs.89.20 crores for the period ended June 30, 2020.
The new greenfield manufacturing facility will be operated alongside the Guwahati facility as a parallel unit thereby helping mitigate the risks of a single-location operation
The company posted net profit of Rs.9.06 crores for the period ended June 30, 2020.
The company posted net profit of Rs.111.44 crores for the period ended June 30, 2020.
The company posted net profit of Rs.594.6 crores for the period ended June 30, 2020.
Subscribe To Our Newsletter & Stay Updated
